现代医药卫生2024,Vol.40Issue(11) :1945-1949.DOI:10.3969/j.issn.1009-5519.2024.11.030

Rett综合征的分子遗传学和治疗研究进展

Advances in molecular genetics and therapy of Rett syndrome

吴浩 钟敏
现代医药卫生2024,Vol.40Issue(11) :1945-1949.DOI:10.3969/j.issn.1009-5519.2024.11.030

Rett综合征的分子遗传学和治疗研究进展

Advances in molecular genetics and therapy of Rett syndrome

吴浩 1钟敏1
扫码查看

作者信息

  • 1. 重庆医科大学附属儿童医院康复科/国家儿童健康与疾病临床医学研究中心/儿童发育疾病研究教育部重点实验室/儿童神经发育与认知障碍重庆市重点实验室,重庆 400014
  • 折叠

摘要

Rett综合征(RTT)为自主神经系统严重病变导致的功能障碍性疾病,目前大多数学者认为其与X染色体上MECP2基因突变有关.RTT患儿主要的临床表现为癫痫、呼吸功能障碍、丧失已学会的手部技能及语言能力等.既往诊断RTT主要依赖于患者特殊的临床表现,制药行业对于RTT的研究几乎仅针对MECP2蛋白下游靶点和改善对症功能.而随着关于RTT的研究不断深入及医疗技术的进步,近年来出现了许多新的治疗策略并取得了重大突破.该文主要收集研究RTT的分子机制和治疗进展的文献进行综述.

Abstract

Rett syndrome(RTT)is a functionally disabling disorder resulting from severe dysfunction of the autonomic nervous system.Currently,the majority of scholars believe it is associated with mutations in the MECP2 gene on the X chromosome.Clinical manifestations in RTT patients primarily include seizures,re-spiratory dysfunction,loss of previously acquired hand skills,and language abilities etc.In the past,the diagno-sis of RTT mainly relied on the specific clinical manifestations of patients,and research on RTT in the phar-maceutical industry almost exclusively focused on downstream targets of MECP2 and improved symptomatic function.With the continuous deepening of research on RTT and the advancement of medical technology,man-y new therapeutic strategies have emerged in recent years and significant breakthroughs have been made.Therefore,in this review,the molecular mechanism and therapeutic progress of RTT were collected and re-viewed.

关键词

Rett综合征/基因突变/遗传/分子机制/治疗/综述

Key words

Rett syndrome/Gene mutation/Genetics/Molecular mechanism/Therapy/Re-view

引用本文复制引用

出版年

2024
现代医药卫生
重庆市卫生信息中心

现代医药卫生

影响因子:0.758
ISSN:1009-5519
段落导航相关论文